VECTOR Pharma is a member of the World Orphan Drug Alliance (WODA). WODA provides full-service solution to pharmaceutical and biotech companies with a portfolio of rare diseases, oncology and highly specialized therapeutics, starting from named patient programs to full commercialization. WODA covers 158 countries in the following regions: Specialised Therapeutics (Australia, New Zealand and Southeast Asia), Medis (Central and Eastern Europe & Nordics), Path Pharma (Greece, Cyprus, Malta), CTS (Israel), Innovative Medicines Group (Latin America), Vector Pharma (Middle East, North Africa, and Turkey), Orpharm (Russia and the CIS region), EffRx (Switzerland), Veld (Africa), Nxera (Japan, South Korea), Theratechnologies (Canada) and its boutique consultancy partner Decisive Consulting.
Al Barsha Boutique Building, 2nd Floor, Flat 212
Al Barsha 1 – Dubai – United Arab Emirates
Building A3, Dubai Silicon Oasis – Dubai – United Arab Emirates
Developed by WSP Reflections